Iron out for nontransfused thalassemia. (abre una nueva ventana)

Marks PW.

Fuente‎: Blood 2012;120(5):928-9.

Indexado en‎: PubMed 22859709

DOI‎: 10.1182/blood-2012-06-433227

https://www.ncbi.nlm.nih.gov/pubmed/22859709 (abre una nueva ventana)

Iron overload in β-thalassemia intermedia: an emerging concern. (abre una nueva ventana)

Musallam KM, Cappellini MD, Taher AT.

Fuente‎: Curr Opin Hematol 2013;20(3):187-92.

Indexado en‎: PubMed 23426199

DOI‎: 10.1097/MOH.0b013e32835f5a5c

https://www.ncbi.nlm.nih.gov/pubmed/23426199 (abre una nueva ventana)

Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. (abre una nueva ventana)

Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE.

Fuente‎: Blood 2012;120(7):1531-2.

Indexado en‎: PubMed 22899478

DOI‎: 10.1182/blood-2012-04-422568

https://www.ncbi.nlm.nih.gov/pubmed/22899478 (abre una nueva ventana)

Prevalance of iron deficiency in thalassemia minor: a study from tertiary hospital. (abre una nueva ventana)

Dolai TK, Nataraj KS, Sinha N, Mishra S, Bhattacharya M, Ghosh MK.

Fuente‎: Indian J Hematol Blood Transfus 2012;28(1):7-9.

Indexado en‎: PubMed 23449336

DOI‎: 10.1007/s12288-011-0088-9

https://www.ncbi.nlm.nih.gov/pubmed/23449336 (abre una nueva ventana)

Therapeutic roles of curcumin: lessons learned from clinical trials. (abre una nueva ventana)

Gupta SC, Patchva S, Aggarwal BB.

Fuente‎: AAPS J 2013;15(1):195-218.

Indexado en‎: PubMed 23143785

DOI‎: 10.1208/s12248-012-9432-8

https://www.ncbi.nlm.nih.gov/pubmed/23143785 (abre una nueva ventana)

Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study. (abre una nueva ventana)

Sutipornpalangkul W, Morales NP, Unchern S, Sanvarinda Y, Chantharaksri U, Fucharoen S.

Fuente‎: J Med Assoc Thai 2012;95(1):29-36.

Indexado en‎: PubMed 22379738

https://www.ncbi.nlm.nih.gov/pubmed/22379738 (abre una nueva ventana)

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. (abre una nueva ventana)

Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD.

Fuente‎: Am J Hematol 2013;88(6):503-6.

Indexado en‎: PubMed 23553596

DOI‎: 10.1002/ajh.23445

https://www.ncbi.nlm.nih.gov/pubmed/23553596 (abre una nueva ventana)